{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-006317","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.979697+00:00","generated_at":"2026-05-17T04:26:45.325481+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Profound Medical reports preliminary Q3 revenue $5.2-5.3M, up 84-87% YoY","bullets":["Preliminary unaudited Q3 2025 revenue of $5.2-5.3M vs $2.8M in Q3 2024, growth 84-87%.","Gross margin expected ~72% compared to 64% in prior-year period.","TULSA-PRO installed base grew to 67 from 60; full-year target of at least 75 systems.","Full Q3 2025 results and conference call scheduled for November 13, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-006317","json":"https://secwatch.observer/filing/0001171843-25-006317.json","markdown":"https://secwatch.observer/filing/0001171843-25-006317.md","text":"https://secwatch.observer/filing/0001171843-25-006317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325006317/0001171843-25-006317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325006317/f8k_100725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:26:45.325481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}